• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adagio Therapeutics, Inc. - Common Stock (NQ:ADGI)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 4.520 (1)
Ask (Size) 4.760 (2)
Prev. Close 4.640
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 109,755,624
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
IVVD FINAL DEADLINE MONDAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
March 30, 2023
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
INVIVYD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI
February 07, 2023
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

More News

Read More
News headline image
NATIONALLY RANKED ROSEN LAW FIRM Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
February 02, 2023
From Rosen Law Firm
Via Business Wire
News headline image
Adagio Pauses FDA Emergency Use Request For Its COVID-19 Therapy ↗
April 14, 2022
Via Benzinga
News headline image
Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA Workshop
December 19, 2022
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer
December 06, 2022
From Invivyd
Via GlobeNewswire
News headline image
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket ↗
August 22, 2022
Via Benzinga
News headline image
Signify Health And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
August 22, 2022
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
August 19, 2022
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
July 27, 2022
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
July 27, 2022
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
July 06, 2022
Via Benzinga
News headline image
Mithril Capital’s Ajay Royan Sends Letter Thanking Adagio Therapeutics Shareholders for Support of Successful Proxy Campaign
July 05, 2022
From Mithril Capital Management LLC
Via Business Wire
News headline image
30 Stocks Moving In Monday's Mid-Day Session ↗
May 23, 2022
Via Benzinga
News headline image
58 Biggest Movers From Yesterday ↗
May 24, 2022
Via Benzinga
News headline image
23 Stocks Moving in Thursday's Pre-Market Session ↗
March 31, 2022
Via Benzinga
News headline image
51 Biggest Movers From Yesterday ↗
March 31, 2022
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Drops 100 Points; Adagio Therapeutics Shares Spike Higher ↗
March 30, 2022
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
March 30, 2022
Via Benzinga
News headline image
S&P 500 Set to Snap 4-Day Win Streak Despite Jobs Data ↗
March 30, 2022
Via Talk Markets
News headline image
Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today? ↗
March 30, 2022
Via InvestorPlace
News headline image
MRNA Stock: What’s Going on With Moderna This Week? ↗
March 30, 2022
Via InvestorPlace
News headline image
SPCE Stock: What’s Going on With Virgin Galactic This Week? ↗
March 30, 2022
Via InvestorPlace
News headline image
Mid-Day Market Update: Crude Oil Surges 3%; Revelation Biosciences Shares Plunge ↗
March 30, 2022
Via Benzinga
News headline image
35 Stocks Moving In Wednesday's Mid-Day Session ↗
March 30, 2022
Via Benzinga

Frequently Asked Questions

Is Adagio Therapeutics, Inc. - Common Stock publicly traded?
Yes, Adagio Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Adagio Therapeutics, Inc. - Common Stock trade on?
Adagio Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Adagio Therapeutics, Inc. - Common Stock?
The ticker symbol for Adagio Therapeutics, Inc. - Common Stock is ADGI on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap